| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 10/24/2006 | CA2152089C Asymmetric process for preparing florfenicol, thiamphenicol, chloramphenicol, and oxazoline intermediates |
| 10/19/2006 | WO2006110155A1 Solid forms of linezolid and processes for preparation thereof |
| 10/19/2006 | WO2006109817A1 1,4-substituted piperazine derivative |
| 10/19/2006 | WO2006108671A1 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 10/19/2006 | WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | WO2006108493A1 Process for preparing oxazole carboxylic esters |
| 10/19/2006 | WO2006108491A1 Improved process for preparing oxazole nitriles |
| 10/19/2006 | WO2006091731A3 Processes for the preparation of linezolid intermediate |
| 10/19/2006 | US20060235060 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 10/19/2006 | CA2603701A1 1,4-substituted piperazine derivative |
| 10/19/2006 | CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | CA2599479A1 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 10/19/2006 | CA2572207A1 Solid forms of linezolid and processes for preparation thereof |
| 10/18/2006 | EP1711478A2 Benzo [d]isoxazol-3-ol daao inhibitors |
| 10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | CA2226669C Herbicidal sulphonylamino(thio)carbonyl compounds |
| 10/12/2006 | WO2006106437A2 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds |
| 10/12/2006 | US20060229316 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them |
| 10/12/2006 | CA2603826A1 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 10/11/2006 | EP1710793A1 Metal chelate compounds and high capacity optical recording medium using the compounds |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1709016A1 Cyclic diamine compound and pharmaceutical containing the same |
| 10/11/2006 | EP1709015A1 Organic compounds |
| 10/11/2006 | EP1709014A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 10/11/2006 | EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 10/11/2006 | EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 10/11/2006 | CN1845923A Intermediate products for producing oxazolidinone-quinolone hybrids |
| 10/11/2006 | CN1845905A PPAR-activating compound and pharmaceutical composition comprising the compound |
| 10/11/2006 | CN1845740A Piperazine derivatives for the treatment of HIV infections |
| 10/11/2006 | CN1279031C Active herbicidal (R)-phenoxypropionic acid-N-methyl-N-2-fluorophenyl amides |
| 10/10/2006 | US7119113 optionally halogenated N-(trifluoromethyloxazol-2-yl)xanthene-9-carboxamides; treatment of neurological disorders such as Alzheimer's disease and dementia |
| 10/10/2006 | US7119112 Sulfonamides as potassium channel blockers |
| 10/10/2006 | US7119105 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 10/10/2006 | CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| 10/10/2006 | CA2255064C Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 10/05/2006 | WO2006105217A2 Spirocyclic thrombin receptor antagonists |
| 10/05/2006 | WO2006103057A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006103045A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
| 10/05/2006 | US20060223868 Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1) |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223726 Photo-labile pro-fragrance conjugates |
| 10/05/2006 | CA2602339A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602336A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | CA2601575A1 Spirocyclic thrombin receptor antagonists |
| 10/04/2006 | EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 10/04/2006 | EP1706387A1 Substituted heterocyclic amides having a fungicidal effect |
| 10/04/2006 | CN1842522A Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 10/04/2006 | CN1842517A 芴衍生物 Fluorene derivatives |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria |
| 10/03/2006 | US7115777 For therapy of hypertension, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty |
| 10/03/2006 | US7115766 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115747 Adduct with zinc chloride-oxazole; Alzheimer's disease |
| 10/03/2006 | US7115654 Caspase-1 inhibitors and methods for their use |
| 10/03/2006 | US7115652 Aspartyl protease inhibitors |
| 10/03/2006 | CA2247946C Anticachectic composition |
| 10/03/2006 | CA2212440C Pharmaceutical preparations for tnf inhibition |
| 09/28/2006 | WO2006102674A2 Diphenylheterocycle cholesterol absorption inhibitors |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | DE102004039533B4 Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexylmethoxy-acetic acid derivatives having substituents, processes for their preparation and their use as medicaments |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
| 09/27/2006 | EP1704143A1 Malononitrile compound as pesticides |
| 09/27/2006 | EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839131A Azolidinecarbonitriles and their use as DPP-IV inhibitors |
| 09/27/2006 | CN1839123A Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids |
| 09/27/2006 | CN1838890A Corrective clothes with liner |
| 09/26/2006 | US7112599 Oxazole compounds for the treatment of neurodegenerative disorders |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/21/2006 | WO2006096994A1 Fluorous oxazolidinone chiral auxiliary compounds and methods of manufacture |
| 09/21/2006 | US20060211863 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211697 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents |
| 09/21/2006 | US20060211677 5-lipoxygenase activating protein inhibitors; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents |
| 09/21/2006 | US20060211656 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 09/21/2006 | US20060210452 Very large scale immobilized polymer synthesis |
| 09/21/2006 | DE102004039532B4 Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexyl-methyloxy-substituted acetic acid derivatives, process for their preparation and their use as medicaments |
| 09/21/2006 | DE102004039509B4 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 09/20/2006 | EP1549624A4 Inhibitors of fatty acid amide hydrolase |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | CN1835935A Stable polymorph of bifeprunox mesilate |
| 09/20/2006 | CN1835934A Oxazole derivatives as inhibitors of cyclooxygenase |
| 09/20/2006 | CN1834095A Nonnucleoside antivirus inhibitor, its prepn. and use |
| 09/20/2006 | CN1834091A Sustituted Gly derivative for treating diabetes and adiposis |
| 09/20/2006 | CN1275950C AB type poly(p-phenyl) benzdioxan monomer and its preparation and use |
| 09/20/2006 | CN1275949C Enantioselective synthesis of azetidinone intermediate compounds |
| 09/19/2006 | US7109376 Benzene and naphthylene derivatives and their use as UV screening agents |
| 09/19/2006 | US7109345 Alkylating an oxazaborolidine, especially using an organolithium or organomagnesium compound; one pot process; the oxazaborolidine may be formed by reacting an amino alcohol with BH3-tetrahydrofuran complex |
| 09/19/2006 | US7109226 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 09/19/2006 | US7109225 Substituted oxazole derivatives |